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Reciprocal signals between microglia and
neurons regulate α-synuclein secretion by
exophagy through a neuronal cJUN-N-
terminal kinase-signaling axis
Dan Ploug Christensen1, Patrick Ejlerskov2, Izabela Rasmussen1 and Frederik Vilhardt1*
Abstract
Background: Secretion of proteopathic α-synuclein (α-SNC) species from neurons is a suspected driving force
in the propagation of Parkinson’s disease (PD). We have previously implicated exophagy, the exocytosis of
autophagosomes, as a dominant mechanism of α-SNC secretion in differentiated PC12 or SH-SY5Y nerve cells. Here
we have examined the regulation of exophagy associated with different forms of nerve cell stress relevant to PD.
Results: We identify cJUN-N-terminal kinase (JNK) activity as pivotal in the secretory fate of autophagosomes
containing α-SNC. Pharmacological inhibition or genetic (shRNA) knockdown of JNK2 or JNK3 decreases α-SNC
secretion in differentiated PC12 and SH-SY5Y cells, respectively. Conversely, expression of constitutively active
mitogen-activated protein kinase kinase 7 (MKK7)-JNK2 and -JNK3 constructs augment secretion. The
transcriptional activity of cJUN was not required for the observed effects. We establish a causal relationship
between increased α-SNC release by exophagy and JNK activation subsequent to lysosomal fusion deficiency
(overexpression of Lewy body-localized protein p25α or bafilomycin A1). JNK activation following neuronal ER
or oxidative stress was not correlated with exophagy, but of note, we demonstrate that reciprocal signaling
between microglia and neurons modulates α-SNC secretion. NADPH oxidase activity of microglia cell lines was
upregulated by direct co-culture with α-SNC-expressing PC12 neurons or by passive transfer of nerve cell-
conditioned medium. Conversely, inflammatory factors secreted from activated microglia increased JNK activation
and α-SNC secretion several-fold in PC12 cells. While we do not identify these factors, we extend our observations
by showing that exposure of neurons in monoculture to TNFα, a classical pro-inflammatory mediator of activated
microglia, is sufficient to increase α-SNC secretion in a mechanism dependent on JNK2 or JNK3. In continuation hereof,
we show that also IFNβ and TGFβ increase the release of α-SNC from PC12 neurons.
Conclusions: We implicate stress kinases of the JNK family in the regulation of exophagy and release of α-SNC
following endogenous or exogenous stimulation. In a wider scope, our results imply that microglia not only inflict
bystander damage to neurons in late phases of inflammatory brain disease but may also be active mediators of
disease propagation.
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Background
Within recent years, it has been convincingly shown that
propagating protein malconformation disease in the
mouse brain can be achieved by inoculation of recombin-
ant α-synuclein (α-SNC) or amyloid-β protein aggregates
[1]. Propagation ensued along anatomically connected
fiber tracts and may reflect the propensity of Parkinson’s
disease (PD) to progress along neuronal trajectories in the
human brain as delineated by Braak et al. [2]. These phe-
nomenological studies are supported by a growing body of
in vitro and in vivo experiments demonstrating interneur-
onal transmission of endogenously produced and secreted
α-SNC [1–7]. Once taken up, the internalized aggregates
engage in proteopathic templating for the perpetuation of
malconformation disease [8]. Thus, there is great interest
in understanding the mechanisms that govern the release
of α-SNC monomers and aggregates under physiological
and pathological conditions, because therapeutic modula-
tion of extracellular α-SNC could be a way to prevent the
propagation of PD once diagnosed. Several groups have
documented neuronal α-SNC secretion [3, 9–14], but
knowledge of the mechanisms that govern secretion is
limited. Both exocytosis of autophagosomes/amphisomes
[10] or late endosomes [11] containing α-SNC have been
proposed as vehicles of α-SNC secretion, but the regula-
tory mechanisms that drives exocytosis, rather than the
classical trafficking pattern to lysosomal fusion and deg-
radation, are largely unknown.
Nerve cells depend on autophagy for proteostasis and
survival due to their post mitotic nature [15]. In PD and
other malconformation brain diseases, where pathology is
associated with abnormal protein folding and aggregate
accumulation, autophagy is activated [16, 17] to compen-
sate for the often compromised proteasomal function.
While α-SNC is taken up by both macroautophagy and
chaperone-mediated autophagy, modified or aggregated
forms of α-SNC have also been found to partially in-
hibit the very same pathways [16–21]. There is also
mounting evidence that lysosomal function is compro-
mised in PD and other brain diseases [22]. Disturbed
trafficking of hydrolases and other lysosomal proteins,
including the vacuolar proton ATPase essential for
acidification, results in a reduced complement of lyso-
somes and their enzymatic activities [23–27]. In addition,
the sequestration of fusion machinery or the aberrant
sorting of PD-associated sorting receptors have been im-
plicated [25, 27, 28] altogether compromising the ability
for an uninterrupted flow through the autophagosomal
and endosomal pathways.
We have recently described how the small, disordered
protein tubulin polymerization-promoting protein (p25α)
perturbs the autophagosomal pathway in parkinsoner-
gic nerve cell models. This small protein, normally
expressed in oligodendrocytes, is ectopically expressed
in dopaminergic neurons in PD, is co-localized with α-
SNC in Lewy bodies, and has a strong propensity to aggre-
gate α-SNC [29]. Therefore, p25α upregulates autophagy
and increases the autophagosomal uptake of α-SNC [10].
However, through its inhibition of histone deacetylase 6
[30], required for actin remodeling [31], p25α also partially
blocks fusion of autophagosomes and amphisomes, the
fusion organelle of an autophagosome and a late endo-
some, with lysosomes [10]. In turn, this greatly increases
the secretion of α-SNC due to the exocytosis of amphi-
somes and/or autophagosomes. Accumulation of autopha-
gosomes and amphisomes is cytotoxic [32], and therefore
secretion of α-SNC via exophagy can be regarded as a last
resort to maintain proteostasis and cell viability [10].
To study autophagy and exophagy of α-SNC in vitro, we
have used the commonly known nerve cell lines PC12 and
SH-SY5Y cells often used as cellular models of dopamin-
ergic neurons. PC12 cells derive from a rat pheochromo-
cytoma and can be differentiated to chatecholaminergic
neuron-like cells in low serum and addition of nerve
growth factor (NGF), while human neuroblastoma cell
line SH-SY5Y can be differentiated to chatecholaminergic,
but predominantly noradrenergic, nerve cells under low
serum concentrations in the presence of either all-trans-
retinoic acid (ATRA) or brain-derived neurotrophic factor
(BDNF). We have transduced these cell lines to condition-
ally express α-SNC (wt or A30P) with or without concur-
rent p25α expression. During our travail, we observed that
p25α expression in both cell types causes the persistent
activation of cJUN-N-terminal kinase (JNK) in the ab-
sence of overt cell death [10]. The JNK family consists
of a number of isoforms divided into JNK1, JNK2, and
JNK3 subtypes. JNK1 and JNK2 are expressed ubiqui-
tously, but JNK3 is primarily expressed in the brain
[33]. All three individual JNK knockouts in mice are vi-
able. While JNK1 is involved with neuronal housekeep-
ing functions such a dendritic arborization, JNK2 and
JNK3 are activated primarily in response to stressful
conditions [33]. Often protracted JNK activation will re-
sult in apoptosis but the anti- and pro-apoptotic functions
of JNK isoforms are controlled by the mitogen-activated
protein kinase kinase kinase dual leucine zipper kinase
(DLK) [34] and the subcellular distribution (nucleus ver-
sus cytosol) of activated JNK [33, 35].
JNK is activated in response to inflammatory signaling.
The transmission hypothesis of malconformation disease
propagation does however not address the role of micro-
glia, the resident central nervous system (CNS) immune
cells, which are essential for development and progression
of neurodegenerative diseases [36]. In the mature brain,
microglia exist in a surveying state [37] but any deviation
from CNS homeostasis, immunological stimuli, or signal-
ing from neurons can activate microglia [36, 37]. However,
protracted activation of microglia, basically due to their
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inability to eradicate the initiating stimulus, causes neuro-
toxic effects by excess production of cytotoxic factors such
as superoxide [38] and tumor necrosis factor α (TNFα)
[39]. Notably, aggregated α-SNC has recently been shown
to activate microglia through Toll-like receptor 2 (TLR2)
[40] and complement receptor 3 (CR3) [41] signaling.
In the present work, we demonstrate that activation of
neuronal stress kinases JNK2 and/or JNK3 is essential for
the exophagosomal release of α-SNC from differentiated
PC12 and SH-SY5Y nerve cells. We find that JNK is acti-
vated not only as a consequence of endogenous stress re-
lating to lysosomal fusion deficiency but also following
inflammatory signaling from co-cultured microglia, which
were themselves activated by the α-SNC secreting neu-
rons. In both instances, activated JNK supports an aug-
mented secretion of α-SNC from neurons. In a broader
scope, our results suggest that inflammatory microglia
also in vivo could modulate release of proteotoxic α-SNC
aggregates from neurons and thereby disease propagation,
in a manner mechanistically different from the well-
documented bystander damage to neighboring neurons in
later phases of disease.
Methods
Antibodies and chemical reagents
Antibodies used were mouse monoclonal anti-α-synuclein
antibody (BD Transduction Laboratories, Franklin Lakes,
NJ); rabbit polyclonal anti-phospho-SAPK/JNK (Thr183/
Tyr185) antibody (#9251, Cell Signaling, Danvers, MA);
rabbit polyclonal anti-phospho-cjun (#2592, Epitomics,
San Francisco, CA); mouse monoclonal anti-β-actin (A-
1978, Sigma-Aldrich, St Louis, MO); rabbit polyclonal
anti-p25α antibody (Enzo Life Sciences, Farmingdale, NY);
mouse monoclonal anti-FLAG tag antibody (#A00187-
200, Genscript, Aachen, Germany); mouse monoclonal
anti-FLAG tag antibody (clone M2, Sigma-Aldrich);
mouse monoclonal anti-JNK1 antibody (F-3) (sc-1648,
Santa Cruz Biotechnology, Dallas, TX); rabbit polyclonal
anti-JNK2 antibody (#4672, Cell Signaling); rabbit mono-
clonal anti-JNK3 antibody (#2305, Cell Signaling); mouse
monoclonal anti-CHOP antibody (Abcam, ab11419);
rabbit polyclonal anti-Nrf2 antibody (sc-22810, Santa
Cruz); rat monoclonal anti-cluster of differentiation 11b
(CD11b) antibody (MCA711, AbD Serotec, Puchheim,
Germany); and rabbit polyclonal anti-TLR2 antibody
(sc-10739, Santa Cruz). Salubrinal, SP600125, phorbol
12-myristate 13-acetate (PMA), lipopolysaccharide
serotype O:55 (LPS), doxycycline, puromycine, Triton X-
100, Tween-20, NADH, sodium pyruvate, trichloroacetic
acid (TCA), phosphatase and protease inhibitors, and
H2O2 were all from Sigma. Human and rat tumor necrosis
factor (TNF)α, rat interleukin (IL)34, rat transforming
growth factor (TGF)β1, rat interferon (IFN)β1, human
brain-derived neurotrophic factor (BDNF), and granulocyte
macrophage-colony stimulating factor (GM-CSF) were all
from Peprotech (Rocky Hill, NJ). Alexa 488-, 568-, or 633-
conjugated goat anti-mouse or anti-rabbit antibodies were
from Molecular Probes (Life Technologies, Grand Island,
NY); horseradish peroxidase (HRP)-conjugated swine or
goat anti-mouse or rabbit secondary antibodies were from
Dako (Glostrup, Denmark); ToPro-3 iodide for nucleus
staining was from Molecular Probes.
Cell culture and neuronal differentiation
The rat pheochromocytoma cell line PC12 (ATCC) was
seeded on collagen-coated culture dishes and cultured in
DMEM containing 10 % horse serum, 5 % fetal calf serum,
and 1 % penicillin and streptomycin at 37 °C in 5 % CO2.
For experiments, PC12 cells were seeded at a density of
45,000 cells/cm2 and differentiated in DMEM containing
2 % horse serum, 1 % penicillin and streptomycin, and
100 ng/ml nerve growth factor (NGF) 2.5S subunit,
(Serotec, Raleigh, NC) for 2 days before transgene
expression was induced for an additional 2 days. Human
neuroblastoma SH-SY5Y cells were cultured in DMEM
containing 10 % fetal calf serum and 1 % penicillin and
streptomycin at 37 °C in 5 % CO2. For experiments, SH-
SY5Y cells were serum starved at high cell density for
5 days and then reseeded and differentiated with 10 μM
all-trans-retinoic acid (ATRA) or 10 μg/ml BDNF in
serum-free medium for 6–8 days to obtain a neuron-like
phenotype. Transgene expression was induced in the last
48 h before experimentation. PC12 cells conditionally (tet-
on) expressing human α-SNC w/wo p25α have previously
been established and described, as have SH-SY5Y cells sta-
bly expressing α-SNC A30P w/wo conditional expression
of p25α [10]. Purification and culture of primary microglia
from neonatal rats was performed as previously described
[42]. The murine microglial cell line Ra2 (licensed by the
Japan Science and Technology Agency, Patent ID
US6.673,6,5; JP3410738; EP10/602,234) was kindly pro-
vided by Dr. Makoto Sawada (Dept. of Brain Function,
Nagoya University, Nagoya, Japan) and maintained in
MEM with 10 % FCS, 1 ng/ml GM-CSF, and 5 μg/ml bo-
vine insulin [10]. Ra2-gp91phox cells with gp91phox under
the control of an elongation factor (EF) promotor have
previously been described [42]. In all instances, doxycyc-
line (100-200 ng/ml) was used to induce transgene expres-
sion for a minimum of 48 h.
Lentivirus production and transduction
Lentivectors SIN-W-PGK-ASK1-K709R and SIN-W-
PGK-Flag-Δ169c-Jun [43] were a generous gift of Dr.
Deglon (CEA, Institute of Biomedical Imaging and
Molecular Imaging Research Center, Orsay, France). Len-
tiviral vectors pLKO.1 JNK1 shRNA (TRCN0000055115),
pLKO.1 JNK2 shRNA (TRCN0000012590), and pLKO.1
JNK3 shRNA (TRCN0000012634) were all from Open
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Biosystems (Dharmacon, Lafayette, CO). Control vector
pLKO.1 scrambled (Scr) shRNA was from Sigma
(#SHC002). Lentiviral particles for infection were pro-
duced as previously described [44] before superinfection
of PC12 cells conditionally expressing α-SNC alone (PC12
α-SNC) or with p25α (PC12 α-SNC/p25α) and SH-SY5Y
cells expressing α-SNCA30P alone (SH-SY5Y α-SNCA30P) or
with conditional p25α expression (SH-SY5Y α-SNCA30P/
p25α). Cells stably expressing scrambled shRNAs were
selected with 0.2 μg/ml puromycin for at least 5–7 days
before beginning differentiation and experimentation. To
generate Ra2 microglia constitutively expressing the
encoded H2O2 sensor HYPER3 [45] (generously provided
by Dr. Belousov, Shemyakin-Ovchinnikov Institute of
Bioorganic Chemistry, Moscow, Russia), complementary
DNA (cDNA) was PCR-cloned into the BamHI/XhoI-re-
stricted lentiviral vector pHR-cPPT.CMV.W expressing
cDNA under the control of the constitutive cytomegalo-
virus (CMV) promotor.
Transient transfections with constitutive active JNK isotypes
Plasmids expressing Flag-tagged constitutively active
versions of JNK1-3 (pCDNA3 Flag MKK7B2Jnk1a1,
pCDNA3 Flag MKK7B2Jnk2a2 and pCDNA3 Flag
MKK7B2Jnk3a1) and kinase dead mutant JNK1 (pCDNA3
Flag MKK7B2JNK1a1(AFP)) are described in [46] and
were obtained through Addgene (Cambridge, MA). Tran-
sient transfection was performed with differentiated SH-
SY5Y α-SNCA30P cells utilizing the Lipofectamine 2000
(Life Technologies) reagent according to the manufac-
turer’s instructions. Conditioned medium was collected,
and cells were lysed for analysis by western blotting for
p-JNK, Flag, and α-SNC, respectively, after an over-
night transfection period.
Western blotting (WB)
Cells were lysed in lysis buffer (100 mm NaCl, 50 mm
Tris-HCl, 1 mm EGTA, 10 mmMgCl2, pH 7.2) containing
1 % Triton X-100, phosphatase, and protease inhibitor
mixture for 5 min at room temperature and thereafter
kept on ice. Cell lysates were centrifuged at 16,100×g for
5 min at 4 °C, and protein concentrations of the super-
natant were determined with Dc protein assay (Bio-Rad,
Copenhagen, Denmark), before the addition of Laemmli
buffer and loading of equivalent protein quantities on
SDS-polyacrylamide gels. Following transfer to PVDF
membranes, western blotting was performed using chemi-
luminescent HRP detection substrate (Millipore, Hellerup,
Denmark). Specifically, for p-JNK in differentiated PC12
cells exposed to Ra2-conditioned medium (Fig. 6e, f ), Ra2
cells were changed to HBSS ± LPS (0.5 μg/ml) ± NGF for
6 h before conditioned HBSS was collected from Ra2
monoculture and centrifuged 6000 rpm at 4 °C for 3 min
prior to transfer to differentiated PC12 cell monoculture
for a 6-h incubation. After 6 h, PC12 conditioned medium
was recovered and cells lysed and prepared for western
blot as described. All western blot bands were quantified
with ImageJ or Image Lab.
Trichloroacetic acid protein precipitation
Conditioned medium was harvested and centrifuged at
800×g for 5 min, 4 °C, before 20 % (v/v) trichloroacetic
acid (TCA) was added to the supernatant and incubated
on ice for 10 min. The protein precipitates were pelleted
by centrifugation (16,100×g, 10 min, 4 °C) and washed four
to five times in ice-cold acetone until the pellet appeared
clear white. The pellets were dried at 95 °C for 20 min,
dissolved in ×2.5 Laemmli buffer, boiled for 20 min at
95 °C, and subsequently processed for western blotting.
Microglia oxidant production
Differentiated PC12 neurons contained in six-wells (ca.
60 % confluency) were incubated with 750.000/well Ra2
microglia expressing HYPER3 in PC12 medium MEM
with additives (as described above). Cells were co-cultured
overnight without (control) or with 100 ng/ml LPS. The
next day, cells were flushed off the culture vessel with
HBSS and immediately analyzed by flow cytometry on a
Beckton Dickinson FACSaria using the 488 nm laser for
excitation of HYPER3. To take advantage of ratiometric
HYPER3 measurements, we also performed a microtiter-
based fluorescence assay. In this format, conditioned
medium from PC12 cells was applied to adherent Ra2
microglia expressing HYPER3 contained in ELISA wells
(50,000/well) for 2 hours before the analysis of HYPER3
fluorescence using a FLEX station at 37 °C with excitation
at 485/420 nm and emission at 516 with cutoff filter set at
495 nm. HYPER3 measurements were performed with
Ra2 microglia receiving only PC12 conditioned medium
(basal) or in addition also 100 ng/ml PMA. Exogenous
H2O2 (100 μM) and DTT (100 mM) were used to obtain
maximal oxidation or reduction of the HYPER3 probe for
comparison.
Lactate dehydrogenase (LDH) assay
To evaluate cell death during our experiments, we col-
lected a small fraction of the aspirated media to be used
for LDH assay. Samples were stored at 4 °C until assay
was performed and maximally 4–6 days. Aspirated
media were centrifuged 6000 rpm, 5 min, at 4 °C to re-
move cell debris before applying 25-μl sample in dupli-
cate to a 96-well plate. Two hundred microliters freshly
prepared reagent solution (0.08 M Trizma Base, 0.2 M
NaCl, 148.5 μg/ml NADH, and 93.5 μg/ml sodium
pyruvate, ph 7.2) was added, and immediately, Abs340nm
was measured for approximately 20 min at room
temperature (1 reading each 20–30 s). The slope of the
resulting Abs340nm change over time was calculated and
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normalized to protein amounts for each sample. All
measurements were related to total cellular content of
LDH obtained by the addition of 0.1 % Triton X-100
to control wells to release all LDH to medium.
Immunofluorescence/confocal microscopy
PC12/Ra2 co-cultures were washed once in Hanks’ bal-
anced saline solution and fixed in a phosphate buffer
containing 2 % paraformaldehyde, pH 7.4, for 30 min.
Immunofluorescence was essentially performed as pre-
viously described [44], and images were acquired with a
Zeiss LSM510 confocal laser scanning microscope with
a C-Apochromat ×63, 1.4 NA oil immersion objective,
using the argon 488-nm and the helium/neon 543- and
633-nm laser lines for excitation of Alexa 488, 568, and
633, respectively. Confocal sections of 0.8–1.0 μm were
collected and saved as 512 × 512-pixel or 1024 × 1024-
pixel images at 12-bit resolution. The same microscopy
settings were used for obtaining all images relating to
the same series of experiments, and images were pre-
pared and compiled without digital manipulation.
Statistical analyses
Comparison between two groups was done by Student’s
t test. Comparisons of more than two groups were done
by one- or two-way ANOVA with either Tukey’s (com-
paring every mean with every other mean) or Dunnett’s
correction (comparing every mean with a control mean)
for multiple comparisons. A p value <0.05 was considered
statistically significant. All data are graphically represented
as means + SEM or given as means ± SD. For Western
blotting, all calculations were performed with actin-
normalized integrated optic density (IOD) where applic-
able or with raw IOD values. Statistical evaluation was
performed with Graphpad Prism.
Results
JNK regulates neuronal secretion of α-SNC
We previously noted that p25α expression in differenti-
ated PC12 nerve cells caused massive and protracted acti-
vation of JNK and its downstream target cJUN alongside a
greatly increased emission of α-syn to the surroundings.
We therefore analyzed JNK activation in more detail. To
detect activated JNK, we performed western blotting of
phosphorylated (p)-JNK and its downstream target cJUN
in whole cell lysates from differentiated PC12 cells ex-
pressing various combinations of α-SNC (wt or A30P) and
p25α over a 6-day culture period after transgene induction
with doxycycline (Fig. 1a). When expressing α-SNCwt or
α-SNCA30P alone, there was a small increase in levels of p-
JNK and p-cJUN compared to control cells transduced
with β-synuclein (β-SNC). In contrast, p25α caused a dra-
matic and persistent activation of JNK and downstream
target cJUN regardless of co-expression of α-SNC.
JNK is known to be involved in regulated trafficking
of vesicular elements along microtubuli tracks [33]. To
investigate if activated JNK plays a role in secretion of
α-SNC, we first tested the effect of SP600125, which is
a potent and reversible inhibitor of JNK. Differentiated
PC12 cells expressing α-SNCA30P either alone or with
p25α were incubated with 10 or 20 μM SP600125 for
48 h (Fig. 1b), and the conditioned medium was ana-
lyzed for secreted α-SNC by TCA precipitation and
western blotting. Following exposure to 10 or 20 μM
SP600125, p-JNK was decreased without affecting cell
death (measured by caspase 3 activation, data not
shown) in a dose-dependent manner in cells expressing
α-SNCA30P/p25α, while the response was biphasic in
PC12 α-SNCA30P cells. ER stress and induction of the
unfolded protein response (UPR) is a common feature of
protein malconformation disease. As JNK can be activated
following ER stress [47], we therefore also examined the
effect of salubrinal, which inhibits dephosphorylation of
phosphorylated eukaryotic Initiation Factor 2α (eIF2α),
and thereby prolongs the UPR to relieve in part the cyto-
toxicity of ER stress [48]. As shown in Fig. 1d–f, 10–20 μM
salubrinal decreased levels of p-JNK as well as secretion of
α-SNC from PC12 α-SNC/p25α expressing cells.
JNK activation is not due to ER stress in p25α-expressing
cells
Our observations that salubrinal decreased p-JNK levels
and α-SNC release prompted us to investigate whether
induction of ER stress is sufficient to activate JNK in p25α-
expressing nerve cells. ER stress mediates JNK activation
through an inositol requiring ezyme-1α (IRE1α)—TNFα
receptor-associated factor 2 (TRAF2)—apotosis signal-
regulating kinase-1 (ASK1) signaling axis [49]. Incidentally,
ASK1 is also a major activator of JNK signaling in response
to oxidative stress [50]. We therefore first examined the ef-
fect of expression of dominant-negative ASK1-K709R in
differentiated PC12 nerve cells. As shown in Fig. 2a, b,
ASK1-K709R was efficiently transduced into PC12 cells;
however, p-JNK levels were in fact moderately upregulated
in these cells (Fig. 2c, d), excluding the IRE1α-TRAF2-
ASK1 axis in the activation of JNK. Secondly, we exposed
ATRA-differentiated SH-SY5Y cells expressing α-SNCA30P
to the ER stressors tunicamycin and thapsigargin, which
induced the UPR as evidenced by upregulation of C/EBP
homologous protein (CHOP) (Fig. 2e). However, neither
agent induced a significant change in the levels of p-JNK
(Fig. 2e, f), and in fact, in BDNF-differentiated SH-SY5Y
cells, these agents moderately decreased JNK activity (see
Fig. 9b, e). In contrast, we note that incubation with bafilo-
mycin A, which inhibits fusion of lysosomes with late
endosomal or autophagosomal organelles, caused accumu-
lation of the autophagosomal marker LC3B-II (Fig. 2e) and
increased p-JNK levels more than twofold in α-SNCA30P-
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Fig. 1 (See legend on next page.)
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expressing SH-SY5Y cells (p < 0.05). Bafilomycin A inhibits
the vacuolar proton ATPase, and as a consequence, inhibits
late endosome or amphisome fusion with lysomes, thereby
mimicking the effect of p25α overexpression [10]. There-
fore, the effect of bafilomycin A was expectedly reduced in
SH-SY5Y cells co-expressing p25α (Fig. 2f). In conclusion,
the observed activation of JNK in PC12 and SHSY-5Y nerve
cells is not due to ER stress or oxidative stress but rather
related to perturbation of membrane trafficking in the
endosomal and/or autophagosomal pathways.
shRNA knockdown of JNK2 or JNK3 reduces neuronal α-SNC
secretion
To identify the JNK isoform(s) in question, we established
PC12 and SH-SY5Y cell lines conditionally expressing α-
SNCwt/p25α or α-SNCA30P/p25α, respectively, together
with stable expression of JNK1, JNK2, or JNK3 shRNA.
These cells were then differentiated to mature neurons
before lysate and conditioned medium were collected for
analysis. We confirmed the knockdown of specific JNK
isoforms by western blotting (Fig. 3a, b) and analyzed α-
SNC secretion by TCA precipitation of the media and
western blotting. We found that knockdown specifically of
JNK2 in PC12 cells (Fig. 3a, d) and JNK3 in SH-SY5Y cells
(Fig. 3b, e) significantly decreased α-SNC secretion com-
pared to control cells expressing scrambled shRNA. Of
note, PC12 cells do not express JNK3 [51]. In differenti-
ated PC12 cells, JNK1 shRNA significantly increased α-
SNC secretion, while JNK1 and JNK2 knockdown in
the differentiated SH-SY5Y cells also increased secre-
tion. To further substantiate that active JNK in neu-
rons is associated with α-SNC secretion, we utilized
dominant-positive JNK1, JNK2, and JNK3 fusion con-
structs (FLAG-MKK7B2-JNK1/2/3). The FLAG-tagged
constructs encode JNK fused to a constitutively active
upstream mitogen-activated protein kinase kinase 7
(MKK7), which persistently activates the JNK moiety
[46]. The FLAG-MKK7B2-JNK1 (AFP) construct is a
JNK kinase dead control. Constructs were transiently
transfected into differentiated SH-SY5Y cells express-
ing α-SNCA30P (Fig. 3c, f–i) to observe whether consti-
tutive JNK activity could replicate the effect of p25α
on α-SNC secretion. The kinase dead AFP-construct
afforded no change in α-SNC release relative to control
cells, active JNK1 moderately increased secretion, but
notably JNK2 and JNK3 isoform transfection many-fold
increased the release of α-SNC (p < 0.05) (Fig. 3f). Both
transfected JNK (FLAG-MKK7B2-p-JNK, Fig. 3c, h) and
endogenous JNK (endo p-JNK, Fig. 3c, g) phosphoryl-
ation were increased, and the highest amounts of en-
dogenous p-JNK were found after JNK2 and JNK3
transfections (p < 0.05 compared to control). No signifi-
cant changes in cell death were detected as assayed by
lactate dehydrogenase (LDH) activity in the medium (data
not shown). The ratio of endogenous p-JNK relative to
FLAG-tagged-p-JNK (Fig. 3i) proved to be highest for the
JNK3 fusion construct, suggesting that similar amounts of
transfected JNK activity (FLAG-p-JNK) pertaining to dif-
ferent isoforms (JNK1-3) caused the highest amount of
endogenous JNK activation (endo p-JNK) for the JNK3
isoform. Hence, JNK3 appears as the most efficient signal-
ing entity for α-SNC secretion of the three investigated.
The effect of p-JNK on α-SNC secretion does not require
the transcriptional activity of cJUN
cJUN is an important transcription factor downstream of
JNK activation, and as shown in Fig. 1a, the persistent
JNK activation correlated with the activation of cJUN by
phosphorylation. We therefore asked whether cJUN-
induced transcription is important for the effects of p-JNK
on α-SNC secretion. For this purpose, PC12 cells express-
ing α-SNC/p25α were transduced with a FLAG-tagged
and truncated dominant-negative cJUN-Δ169 construct,
which retains DNA binding, but has lost its transactivation
domain. Figure 4a, b shows that cJUN-Δ169-FLAG was
efficiently transduced into the vast majority of cells and
expressed as a protein of the expected size (ca. 20 kDa),
which localized to the nucleus. However, we found that
dominant-negative cJUN did not significantly alter the
level of secreted α-SNC to the medium (Fig. 4c, d), and
we conclude that the effect of p-JNK on α-SNC release
is not related to cJUN-induced transcriptional effects.
Differentiated PC12 neurons expressing α-SNC activate
microglia cells in co-culture to produce oxidants
It has recently been shown that oligomeric α-SNC via
binding to TLR2 or CR3 can activate microglia to produce
inflammatory cytokines (e.g., TNFα and interleukin-1β)
(See figure on previous page.)
Fig. 1 Pharmacological JNK inhibition reduces α-SNC secretion from neurons. a Lysates of differentiated PC12 cells expressing α-SNC and/or p25α
for 1–6 days after transgene induction were western blotted with antibodies as indicated. The blots shown are representative of three independent
experiments. b PC12 cells expressing α-SNCA30P or α-SNCA30P/p25α were treated with JNK inhibitor SP600125 (10 and 20 μM) for 48 h before subjecting
whole cell lysates and protein precipitated from conditioned media (TCA) to western blotting as indicated. c Quantification of b. Data are presented as
mean + SEM (N = 3) normalized to “α-SNCA30P Control” (ϕ: p < 0.05 compared to “α-SNCA30P Control”; **p < 0.01 compared to “α-SNCA30P/p25α
Control”). d PC12 cells expressing α-SNCA30P/p25α were treated with salubrinal (10 and 20 μM) for 48 h before whole cell lysate, and protein
precipitated from conditioned medium (TCA) were subjected to WB analysis. e–f Quantifications of d. Data are presented as mean + SEM (N = 3)
percent normalized to untreated control cells (*p < 0.05 compared to “Control”)
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and mediate chemotaxis [40, 41]. The phagocyte NADPH
oxidase (NOX2) is activated in response to many different
stimuli, and the degree of either activation (superoxide
production) or priming (hyper-responsiveness to stimuli)
is a very sensitive measure of cell activation. When we in-
cubated Ra2 microglia expressing the genetically encoded,
fluorescent H2O2-sensor HYPER3 [45] with differentiated
PC12 cells expressing either α-SNCwt or α-SNCwt/p25α in
direct co-culture, we found that PC12 nerve cells express-
ing α-SNC, and even more so α-SNC/p25α, enhanced
microglial NADPH oxidase activity compared to microglia
monoculture. When microglia were primed with LPS
(100 ng/ml), HYPER3 fluorescence was augmented further
and again showed a p25α-dependent increase. Analysis of
the conditioned media from these co-cultures showed that
regardless of p25α expression, secretion of α-SNC was up-
regulated by LPS stimulation of the microglia (p < 0.05,
Fig. 5a, b). The factor(s) emitted from neurons to activate
microglia were soluble mediators as the effect could be
replicated by passive transfer of PC12 conditioned
medium to the Ra2 microglia (Fig. 5c–e). Resting or
LPS-stimulated Ra2 microglia expressing HYPER3 were
incubated with conditioned medium from PC12 cells
expressing α-SNC with or without p25α for 2 hours before
basal or PMA-induced oxidant production was measured
by ratiometric HYPER3 fluorescence in a microtiter plate
reader. Again, we found that PC12 cells expressing α-SNC
increased microglial oxidant production, and this was fur-
ther increased by p25α co-expression either under basal
or PMA-stimulated conditions (Fig. 5c–e). Microglia cells
incubated with LPS were particularly susceptible to activa-
tion by conditioned medium from α-SNC-expressing
PC12 cells compared to control cells (p < 0.05) (Fig. 5e).
Fig. 2 ER stress does not mediate JNK activation in differentiated PC12
or SH-SY5Y nerve cells. a–d PC12 cells expressing α-SNC/p25α were
transduced with control vector or dominant-negative ASK1-K709R
(ASK1-DN) with a viral dose of 25 or 50 μl. a Two days post-infection
cells transduced with control or 50 μl ASK1-DN vector were prepared
for immunofluorescence with anti-ASK1 antibodies. Bar, 10 μm. b PC12
α-SNC/p25α cells transduced with control or ASK1-DN vector were
stained with anti-ASK1 antibodies and analyzed by flow cytometry.
Results are expressed as mean fluorescent intensity (MFI) of ASK1 staining
(mean and SEM, N= 2). c Cell lysates prepared from transduced PC12
cells were western blotted using anti-p-JNK antibodies. d Densitometric
quantitation of p-JNK western bands from above. Results are
expressed as mean integrated optical density (IOD) normalized to
control-transduced cells (mean and SEM, N= 4). e, f ATRA-differentiated
SHSY-5Y cells expressing α-SNCA30P alone or together with p25α were
treated overnight with tunicamycin (Tun; 700 nM), thapsigargin (Thaps;
25 nM), or bafilomycin A (Baf; 20 nM). e Cell lysates were then western
blotted with anti-CHOP, anti-LC3B, and anti-p-JNK antibodies. All lanes
shown for each respective antibody were derived from the same
membrane. f Densitometric quantitation of p-JNK western bands from
above. Results are expressed as mean and SEM integrated optical
density (IOD) normalized to (respective) control-transduced cells (N= 3,
*p < 0.05 by Student t test compared to control)
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Fig. 3 (See legend on next page.)
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Thus, substance(s) released from synucleinopathic dif-
ferentiated neurons can activate microglia. It has been
described that both CD11b [41] and TLR2 [40] function
as signaling and/or phagocytic receptors of α-SNC.
We therefore conducted co-culture experiments with
or without LPS activation of microglia and then per-
formed immunofluorescence to gauge internalization
of α-SNC and potential interaction with these sur-
face receptors. As shown in Fig. 5, the increased
secretion of α-SNC afforded by LPS activation of
microglia correlated with uptake into Ra2 microglia,
where colocalization with TLR2 was evident (arrows
in Fig. 5f ).
Activated microglia release substance(s) that activate
neuronal JNK signaling and increase neuronal α-SNC
secretion
As seen in Fig. 5a, b, LPS activation of microglia in co-
culture greatly increased the secretion of α-SNC from
neurons regardless of p25α expression. We further vali-
dated these results with primary rat microglia. Figure 6a, b
shows that primary microglia activated by LPS caused a
fourfold increased release of α-SNC from PC12 cells ex-
pressing α-SNC alone (p < 0.05 compared to control),
again without excessive cell death as measured by LDH
release (data not shown). The microglia redox state is
intimately tied to microglia activation [52]. Therefore,
we also analyzed the effect of overexpression of gp91phox,
the rate-limiting subunit of the cyt b558 flavocytochrome
complex of NADPH oxidase, in Ra2 microglia. As seen in
Fig. 6c, gp91phox overexpression in microglia caused an in-
creased secretion of α-SNC from neurons in direct co-
culture both in basal or LPS-primed states of the microglia.
The effect of gp91phox in microglia on neuronal secretion
of α-SNC was not due to a direct effect of (short-lived) oxi-
dants on the nerve cells, as the effect could be replicated
by passive transfer of microglia conditioned medium to
neuron monoculture (Fig. 6d). Secondly, we addressed if
microglial signaling to increase neuronal α-SNC secre-
tion was associated with neuronal JNK activation. To
assess p-JNK levels accurately, these assays were per-
formed in the absence of serum to avoid JNK activation
associated with mitogenic signaling. Differentiated PC12
cells expressing α-SNC in monoculture were exposed
to conditioned media from Ra2 microglia monocultures
+/−LPS (100 ng/ml) exposure (Fig. 6e, f ) with or with-
out the addition of NGF. NGF has been shown to be
important for maintaining PC12 cells in a differentiated
state and to prevent apoptosis [53]. In agreement with
previous experiments (Fig. 6a, b), we found that LPS
alone had either no or little effect on neuronal JNK
phosphorylation and α-SNC secretion. When differenti-
ated PC12 cells were exposed to conditioned medium
from control Ra2 microglia, there was no change in p-
JNK levels but a decrease (although not statistically
significant) in α-SNC secretion. However, conditioned
medium transferred from inflammatory Ra2 microglia
activated with LPS caused a statistically significant in-
crease in p-JNK levels (p < 0.05 compared to PC12 cells
with unexposed Ra2) associated with an increased α-
SNC release, which in serum-free conditions is some-
what lower than in the presence of serum (compare
Figs. 5b with 6f ). The presence of NGF did not alter
the response (Fig. 6f ). Lastly, we performed confocal
imaging with differentiated PC12 cells expressing α-
SNCwt and Ra2 microglia +/−LPS in co-culture to ver-
ify by independent methods that LPS-stimulated Ra2
microglia indeed caused an increase in p-JNK immuno-
reactivity in PC12 nerve cells (Fig. 6g). LDH release to
medium was measured to estimate cell death (data not
shown). In all cases, LPS exposure or microglia condi-
tioned medium did not cause a biologically significant
increase in cell death (the highest measure was a mean
increase of Δ3.3 ± 0.9 % (p < 0.05) for cells exposed
overnight to conditioned medium from LPS-primed
microglia compared to control cells in monoculture).
(See figure on previous page.)
Fig. 3 JNK2 or JNK3 shRNA reduce while JNK activation increases α-SNC secretion from neurons. a PC12 cells expressing α-SNC/p25α and JNK1,
JNK2, or JNK1+2 shRNA were lysed after 48 h transgene induction and whole cell lysates and conditioned media (TCA) were subjected to western
blotting against JNK1, JNK2, and α-SNC. Showing representative images from two to three independent experiments (we performed only two
experiments with JNK1+2 shRNA expressing cells). b Differentiated SH-SY5Y cells expressing α-SNC/p25α and JNK1-3 shRNA were lysed after 48-h
transgene induction, and whole cell lysates and conditioned media (TCA) were western blotted as indicated. The blots shown are representative
of three independent experiments. c Differentiated SH-SY5Y cells expressing α-SNC/p25α were transfected with plasmids encoding constitutively
active (FLAG-MKK7B2-JNK1-3) JNK isoforms or a kinase dead version of JNK1 (AFP) as control. The day after transfection, whole cell lysates and
conditioned media (TCA) were western blotted as indicated. The blots shown are representative of three independent experiments. d Quantification
of a α-SNC present in conditioned medium. Data are shown as mean + SEM (N = 3) percent relative to control transfected with scrambled (Scr) shRNA
(*p < 0.05; ***p < 0.001 compared to “Scrambled”). e Quantification of b α-SNC present in conditioned medium. Data are shown as mean + SEM (N = 3)
percent relative to control transfected cells (**: p < 0.01 compared to “Scramble”). f-h Quantification of (C) α-SNC present in conditioned
medium (TCA), endogenous (Endo) p-JNK, and FLAG-MKK7B2-JNK1-3 (FLAG) p-JNK. Data are presented as mean + SEM (N = 3) normalized to
control cells transfected with an empty vector (*p < 0.05; **p < 0.01; ***p < 0.001 compared to “Control”). i Calculated ratio of p-JNK of
endogenous to FLAG-MKK7B2-JNK1-3 densitometric western blot signals
Christensen et al. Journal of Neuroinflammation  (2016) 13:59 Page 10 of 21
TNFα exposure increases neuronal JNK phosphorylation
and α-SNC secretion
The pro-inflammatory cytokine TNFα is an important ef-
fector of inflammatory microglia and is associated with
disease progression in animal models of PD [39]. There-
fore, we wanted to investigate if exogenously added TNFα
could influence neuronal p-JNK levels and α-SNC secre-
tion. Differentiated PC12 or SH-SY5Y cells were exposed
to recombinant rat or human TNFα, respectively, in a
concentration (Fig. 7a–c)- and time (Fig. 7d–f )-dependent
manner. In differentiated PC12 and SH-SY5Y cells ex-
pressing α-SNCwt or α-SNCA30P, respectively, there was a
TNFα dose-dependent increase in α-SNC secretion to the
medium accompanied by an increase in p-JNK and its
downstream target p-cJUN levels after 18 h exposure
(Fig. 7a–c). In both cell types, exposure to TNFα for 18 h
in the low ng/ml range (2–5 ng/ml) led to a significant
increase in α-SNC secretion compared to control (0 ng/ml
TNFα) (p < 0.05). Two concentrations of TNFα were
chosen for 6 and 12 h exposures of differentiated PC12
cells expressing α-SNCwt (10 and 25 ng/ml) and differenti-
ated SH-SY5Y cells expressing α-SNCA30P (2 and 5 ng/ml)
(Fig. 7d–f ). Already after 6-h exposure to the highest
TNFα concentration, we detected a slightly increased α-
SNC level in the conditioned media of both PC12 and
SH-SY5Y cells. After 12 h of exposure to the highest con-
centration, there was a clear and statistically significant
increase in α-SNC levels in the media of both differenti-
ated PC12 and SH-SY5Y cells (p < 0.05) (Fig. 7e–f ). The
increased levels of secreted α-SNC were correlated with
increased p-JNK levels in the whole cell lysates (Fig. 7d).
Additionally, when comparing conditions with low and
high TNFα concentrations, it appeared that within each
time point was a dose-dependency as observed above. Col-
lectively, the data indicate that direct exposure of neurons
to TNFα suffices to increase JNK activation and α-SNC
secretion.
JNK is required for TNFα to augment α-SNC secretion
To address the possibility of a causal relationship for
JNK in the TNFα-mediated increase in α-SNC secretion
from neurons, we knocked each of the three JNK
isoforms down with shRNAs. Then differentiated PC12
and SH-SY5Y cells expressing JNK shRNAs together
with α-SNCwt or α-SNCA30P, respectively, were subjected
to TNFα exposure (Fig. 8a–d). For each cell line, we
chose two TNFα concentrations and since JNK3 is not
present in PC12 cells, we used only JNK1 or JNK2
shRNA in PC12 cells. In all cases, p-JNK levels and JNK
knockdown were confirmed by p-JNK and JNK im-
munoblotting of whole cell lysates. Stable expression of
JNK2 or JNK3 shRNA decreased α-SNC secretion from
PC12 α-SNCwt and SHSY5Y α-SNCA30P cells (Fig. 8c, d,
control) indicating that JNK is involved in α-synuclein
B
A
C
D
Fig. 4 p-JNK effects on α-SNC secretion do not depend on the tran-
scriptional activity of cJUN. PC12 cells expressing α-SNC/p25α were
differentiated with NGF and transduced with control vector or a
dominant-negative cJUN-Δ169-FLAG construct in doses of viral
supernatant of 25 or 50 μl before transgene (α-SNC/p25α) induction
with doxycycline. a Four days post-infection cells were prepared for
immunofluorescence with anti-FLAG antibodies as indicated.
Alexa647-conjugated phalloidin (F-actin) was used as counter stain.
Bar, 10 μm. b Cell lysates were prepared for western blotting with
anti-FLAG mAb for the detection of cJUN-Δ169-FLAG. Arrow
indicates 25 kDa weight marker. The WB is the representative of
two independent experiments. c Conditioned medium from transduced
cells as above was analyzed for α-SNC by western blotting. All lanes
were derived from the same membrane. d Normalized mean and
SEM integrated optical density of α-SNC western bands above for
four independent experiments
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Fig. 5 PC12 cells expressing α-SNC activate microglia cells to produce oxidants. a PC12 cells expressing α-SNC or α-SNC/p25α were co-cultured
with unstimulated or LPS (100 ng/ml)-primed Ra2 microglia expressing the H2O2 biosensor HYPER3 overnight prior to the measurement of
HYPER3 fluorescence by flow cytometry. Data are presented as mean relative fluorescent units (RFLU) +SEM. Conditioned medium was collected
for WB analyses of α-SNC (inset). Data and representative image from three independent experiments. b Quantification of α-SNC in conditioned
media from a. Data are presented as mean + SEM normalized to α-SNC-expressing PC12 cells (α-SNC) (*p < 0.05, N = 3). c Conditioned media were
collected from PC12 cells expressing α-SNC or α-SNC/p25α after 2 days on transgene expression and transferred to Ra2 microglia expressing
HYPER3. After a 2-h incubation, HYPER3 fluorescence was measured for 60 min without (Basal) or with 100 ng/ml PMA to activate NADPH oxidase.
Data from a single experiment performed in triplicate wells is presented as a 485/420 nm ratio of Hyper3 fluorescence (RFLU). d Same as c but
microglia were exposed to LPS (100 ng/ml) overnight prior to challenge with PC12-conditioned medium. 100 mM DTT or 100 μM H2O2 was added to
obtain emission of the fully reduced/oxidized HYPER3 biosensor probe for comparison. Data from a single experiment performed in triplicate wells is
presented as a 485/420 nm ratio of HYPER3 fluorescence (RFLU). e Bar graphs showing quantification of maximal oxidant response from (c–d). Data
are presented as mean + SEM percent normalized to control cells (*p < 0.05, N = 3). f PC12 neurons expressing α-SNC were co-cultured with
Ra2 microglia in the absence (top row, control) or presence of 100 ng/ml LPS (6 h, bottom row). Immunofluorescence stain shows the distribution
of α-SNC, CD11b, and TLR2 as indicated. Right side panels show outlined cell in presence of LPS at higher magnification to demonstrate colocalization
of α-SNC with CD11b and in particular TLR2. Bar, 10 μm
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metabolism also in the absence of p25α expression (see
Fig. 3). Expectedly (Fig. 7), TNFα mediated an increased
α-SNC secretion, which correlated with the activation of
JNK (Fig. 8a–d, scrambled shRNA [Scr]). Importantly,
the specific knockdown of JNK2 in PC12 cells or JNK3
in SHSY-5Y cells reduced the ability of TNFα to increase
Fig. 6 LPS-activated microglia increase neuronal α-SNC secretion and JNK phosphorylation. a PC12 cells expressing α-SNC were incubated in monoculture
(neurons) or together with primary microglia isolated from neonatal rats (neurons + microglia) with or without 100 ng/ml LPS overnight. Conditioned
medium was then analyzed for secreted α-SNC. The blot shown is representative of four independent experiments. b Quantification of a secreted α-SNC
mean fold increase + SEM relative to control (**p < 0.01 compared to control, N = 4). c PC12 cells expressing α-SNCA30P or α-SNCA30P/p25α were
cultured together with Ra2 microglia or Ra2 overexpressing gp91phox (Ra2-gp91phox) for increased oxidant production. Conditioned media was
analyzed for secreted α-SNC. Images are representative of two independent experiments. d Media collected from Ra2 or Ra2-gp91phox microglia with
or without overnight exposure to 100 ng/ml LPS were transferred to differentiated PC12 cells expressing α-SNCA30P in monoculture. After overnight
incubation, the conditioned medium was collected and analyzed by western blotting. The blot shown is representative of two independent
experiments. e Ra2 microglia were exposed to 500 ng/ml LPS in HBSS (Ra2 + LPS) with or without NGF for 6 h before transferring Ra2-
conditioned HBSS to differentiated PC12 cells expressing α-SNC in monoculture. After 6 h of incubation, whole cell lysates and conditioned
media were collected for WB analysis of p-JNK and secreted α-SNC, respectively. The blot shown is representative of three independent experiments.
f Quantification of p-JNK (lysate) and α-SNC (TCA) in e. Mean fold increase + SEM relative to LPS alone (*p < 0.05 compared to “Ra2”; #p < 0.05
compared to “NGF Ra2”). g PC12 cells expressing α-SNCwt in monoculture (PC12) or co-culture with Ra2 microglia (PC12 + Ra2) were incubated with
100 ng/ml LPS for 6 h prior to fixation and analysis for p-JNK and neurofilament (NF) by immunofluorescence. Slides were examined in a LSM510
confocal laser microscope. Representative images from two to three independent experiments are shown. Bars, 5 μm
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Fig. 7 TNFα stimulation suffices to increase neuronal JNK phosphorylation and α-SNC secretion. a PC12 and SH-SY5Y cells expressing α-SNC and
α-SNCA30P, respectively, were stimulated with TNFα at indicated concentrations for 18 h. Whole cell lysate and conditioned media (TCA) were collected
and analyzed by WB. The blot shown is representative of three independent experiments. b Quantification of α-SNC in conditioned media from PC12
cells in a (*p < 0.05 and **p < 0.01 compared to “0 ng/ml”). Data are presented as mean fold increase + SEM (N = 3) relative to “0 ng/ml”
control. c Quantification of α-SNC present in media from SH-SY5Y cells in a (*p < 0.05 and **p < 0.01 compared to “0 ng/ml”). Data are presented as
mean fold increase + SEM (N = 3) relative to “0 ng/ml” control. d PC12 and SH-SY5Y cells expressing α-SNC and α-SNCA30P, respectively, were stimulated
with TNFα at indicated concentrations for 6 and 12 h. Whole cell lysate and conditioned media (TCA) were collected and analyzed by WB. The blot
shown is representative of three independent experiments. e Quantification of α-SNC present in conditioned medium from PC12 cells in d (**p < 0.01
compared to “0 ng/ml”). Data are presented as mean fold increase + SEM (N = 3) relative to “0 ng/ml” control. f Quantification of α-SNC present in
media from SH-SY5Y cells in d (**p < 0.01 compared to “0 ng/ml”). Data are presented as mean fold increase + SEM (N = 3) relative to “0 ng/ml” control
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α-SNC secretion from the nerve cells indicating that
JNK activation is an essential component of inflamma-
tory signaling-induced α-SNC secretion. Cell death was
assessed by LDH assay. Exposure to 10 and 25 ng/ml
recombinant TNFα in the presence of JNK1 shRNA in
PC12 cells (Fig. 8a, c) significantly increased cell death
from 3.1 % ± 0.7 to 23.9 % ± 7.2 (p < 0.05) and 28.6 ±
11.7 (p < 0.05 compared to controls), respectively. Ex-
posure of SH-SY5Y cells expressing JNK2 shRNA to 2
and 5 ng/ml recombinant TNFα increased (although
not statistically significant) cell death from 8.2 % ± 3.5
to 28.9 % ± 7.2 and 28.6 % ± 11.7, respectively. The large
Fig. 8 TNFα-induced α-SNC secretion from neurons requires JNK2 or JNK3, and non-inflammatory cytokines can increase α-SNC secretion. a PC12
cells expressing α-SNC and JNK1, JNK2, or scrambled control (Scr) shRNA were stimulated with TNFα (10 or 25 ng/ml) overnight. Whole cell lysate
and conditioned media (TCA) were collected and analyzed by WB. Showing representative images from three independent experiments. b Differentiated
SH-SY5Y cells expressing α-SNCA30P and JNK1, JNK2, JNK3, or scrambled shRNA were stimulated with TNFα (2 or 5 ng/ml) overnight. Whole cell lysates
and conditioned media (TCA) were collected and analyzed by WB. The blot shown is representative of three independent experiments. c Quantification
of secreted α-SNC (TCA) in a. Data are presented as mean fold increase + SEM (N = 3) relative to control “Scr” shRNA (*p < 0.05 and **p< 0.01 compared
to Scr shRNA in “Control.” p values are based on comparison with Scr shRNA within each group, i.e., 10 or 25 ng/ml). d Quantification of secreted α-SNC
(TCA) in b. Data are presented as mean fold increase + SEM (N = 3) relative to control “Scr” shRNA (**p < 0.01 compared to “Control”). e PC12
cells expressing α-SNCA30P were stimulated overnight with 100 ng/ml LPS or 10 ng/ml IL34, TGFβ1, or IFNβ1. Conditioned media (TCA) were
collected and analyzed by WB. Showing representative image from three independent experiments. f Quantification of monomeric α-SNC in
e. Data are presented as mean fold increase ± SEM (N = 3) relative to “Control” (**p < 0.01 and ***p < 0.001 compared to “Control”)
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increases in α-SNC levels in the conditioned medium
from these conditions (only) are therefore not due to
an active release mechanism.
Non-inflammatory cytokines can also modulate α-SNC
secretion from neurons
Since exposure to the pro-inflammatory cytokine TNFα
increased neuronal secretion of α-SNC, we also exam-
ined the effect of several non-inflammatory cytokines on
neuronal α-SNC secretion. Differentiated PC12 cells ex-
pressing α-SNCA30P in monoculture were incubated with
interleukin (IL)34, transforming growth factor (TGF)β1,
or interferon (IFN)β1 at a concentration of 10 ng/ml.
TGFβ1 is considered a master negative regulator of
inflammation; IFNβ1 is a classical anti-viral and anti-
bacterial cytokine, while IL34, which binds to colony-
stimulating factor-1 receptors present on PC12 cells, was
recently shown to increase microglia-afforded neuropro-
tection in an animal model of Alzheimer’s disease [54]. In
addition, we also added LPS previously shown to have no
effect in monoculture (Fig. 6a–d). As seen in Fig. 8e, f,
both TGFβ1 and IFNβ1 affected neuronal α-SNC secre-
tion as seen by a statistically significant increase in α-SNC
levels in the conditioned media from PC12 monocultures
(p < 0.01 and p < 0.001, respectively, compared to control).
Neither LPS nor IL34 affected secretion.
The correlation between JNK activation and α-SNC secretion
relates to specific stress conditions
As a stress kinase and a mitogen-activated protein kinase,
JNK is activated by many different factors and conditions
in neurons. Therefore, we examined the universality of the
correlation between activation of JNK and secretion of α-
SNC into the surroundings. For the purpose, we imposed
either ER stress with tunicamycin or thapsigargin expos-
ure or alternatively oxidative stress generated by xanthine/
xanthine oxidase production of superoxide, on PC12 and
BDNF-differentiated SH-SY5Y cells expressing α-SNCwt
or α-SNCA30P, respectively. Both stress conditions are
highly relevant in the context of neurodegenerative disease
and PD. As shown in Fig. 9a–c, ER stress or oxidative
stress specifically upregulated CHOP as a marker of ER
stress (p < 0.05 tunicamycin in PC12 and thapsigargin in
SH-SY5Y compared to Cont.) and Nrf2 as a marker of oxi-
dative stress (p < 0.05 compared to control), respectively,
in either cell type. The expression levels of transcription
factor ATF3, which is transcriptionally regulated by Nrf2,
closely followed the expression levels of Nrf2 in both
cell types (data not shown). While ER stress induced
with thapsigargin caused JNK activation in PC12 cells
(p < 0.05 compared to control), both tunicamycin and
thapsigargin moderately downregulated p-JNK in SH-
SY5Y cells (p < 0.05 compared to control, Fig. 9a, d). Note
that JNK in SH-SY5Y cells is activated differentially
following ER-stress induction with thapsigargin de-
pending on either ATRA (Fig. 2e, f ) or BDNF differen-
tiation (Fig. 9a, d). In PC12 cells, both tunicamycin (not
significant) and thapsigargin (p < 0.05 compared to con-
trol) increased α-SNC secretion to the medium, while
preferentially thapsigargin caused α-SNC secretion in
SH-SY5Y cells (p < 0.05). In neither cell type did oxida-
tive stress under the experimental conditions cause ac-
tivation of JNK, but nevertheless, α-SNC secretion was
increased in both cell types particularly SHSY-5Y cells
(p < 0.05, Fig. 9a, e). We therefore conclude that secre-
tion of α-SNC under conditions of cellular stress (dif-
ferent from lysosomal perturbation and inflammatory
signaling) does not necessarily correlate with JNK acti-
vation. Note that in the above experiment, released α-
SNC may not necessarily derive from exophagy but
could be due to other mechanisms of unconventional
secretion. The essentiality of JNK2 and JNK3 for α-
SNC secretion that we have described in the preceding
sections therefore seems to be specifically tied to cer-
tain types of either intrinsic (autophagosomal and/or
lysosomal perturbation) or extrinsic (inflammatory sig-
naling) stress.
Discussion
Within just a few years, a substantial body of evidence has
emerged to support the idea that α-synucleinopathy can
spread through the brain via release of proteotoxic α-SNC
species from an affected neuron and uptake by a neigh-
boring neuron [55]. Once internalized, these species can
confer misfolding disease through proteopathic templating
and thereby perpetuate the disease. The mechanism of
neuronal α-SNC release is under intense investigation,
and both late endosomes [11] and amphisomes [10], the
organelles derived from fusion between autophagosomes
and late endosomes, have been proposed as vesicular
carriers of α-SNC to the surroundings by exocytosis. Note
that exosomes, small intra-luminal vesicles contained
within late endosomes and purported to contain or
bind misfolded protein, are released in both cases. In
the current study, we pinpoint active (phosphorylated)
JNK in differentiated nerve cells as a pivotal regulator
of α-SNC secretion by exophagy in response to both
internal and external stress factors. With respect to the
latter, we specifically show that classically activated
microglia, and their inflammatory mediators such as
TNFα, substantially augment α-SNC secretion from
neurons.
Active JNK is required for exophagy of α-SNC from
differentiated neurons
We find that p25α, which partially inhibits fusion of late
autophagosomal elements with lysosomes [10], caused per-
sistent phosphorylation and activation of JNK accompanied
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by phosphorylation of downstream target cJUN to a
much higher degree than α-SNC expression alone. How-
ever, pharmacological (SP600125) or genetic (JNK2/3
shRNA) JNK knockdown decreased, whereas constitutive
active JNK signaling (MKK7B-JNK fusion constructs) in-
creased α-SNC release from nerve cells regardless of p25α
expression.
JNK1 has many “house-keeping” functions, while
JNK2 and JNK3 are preferentially activated in response
to cellular stress [33]. The mixed lineage kinase DLK is
involved in the regulation of the pro-apoptotic versus
physiological functions of the JNKs [34]. We show that
knockdown of JNK2 in PC12 cells and JNK3 in SH-SY5Y
cells significantly and robustly downregulated α-SNC
release from cells co-expressing p25α (Fig. 3). Notably,
JNK3 is not expressed in PC12 cells, and a certain degree
of redundancy between JNK isoforms has been noted in
global knockout studies in rodents [33] perhaps explaining
the dependency on JNK2 in these cells. Conversely, of the
constitutively active JNK1, JNK2, and JNK3 fusion con-
structs expressed in differentiated SH-SY5Y cells, JNK2
and JNK3 most effectively increased α-SNC secretion and,
if any, JNK3 appeared to be the most efficient signaling
JNK entity in relation to α-SNC release, as well as activa-
tion of endogenous JNK. Although JNK target cJUN was
consistently phosphorylated in p25α-expressing cells, we
find that its transcriptional activity is not required for
the JNK effect on α-SNC secretion, as co-expression of
dominant-negative cJUN did not alter α-SNC secretion
(Fig. 4). This indicates that JNK2 and JNK3 modify the ac-
tivity of cytosolic targets to effect increased exophagy.
Salubrinal inhibited both JNK activation and α-SNC
secretion in PC12 nerve cells. However, expression of
dominant-negative ASK1-K709R, which inhibits signal-
ing through the classical ER-stress IRE1α-TRAF2-ASK1
signaling axis terminating in p38-mitogen-activated pro-
tein kinase and JNK activation [47], failed to decrease
phosphorylation of JNK. For the same reasons, oxidative
stress, which also signals through ASK1, is not the cause
of JNK activation in p25α-expressing cells [50]. Instead,
we consider that the mechanism of JNK activation fol-
lowing p25α-associated stress relates to the perturbation
of lysosomal fusion with amphisomes [10]. Thus, in both
PC12 and SH-SY5Y cells, bafilomycin, which more effi-
ciently than p25α inhibits lysosomal fusion reactions,
caused profound JNK activation (and α-SNC secretion).
These observations are perhaps supported by drosophila
studies showing JNK activation in response to accumula-
tion of dysfunctional late endosomes [56]. The association
of JNK isoforms with vesicular compartments through
protein scaffolds or adaptor proteins that bind to either
kinesin and dynein microtubule motors is well noted [57],
and both cargo association [58–60] and mobility are regu-
lated by JNK activity [59]. Thus, JNK3 in part determines
directional organelle mobility in zebra fish axons [61] and
has also been associated with aberrant directional cargo
transport in response to pathogenic huntingtin as a basis
of neurodegeneration [62]. The lack of retrograde move-
ment of prelysosomal and lysosomal compartments may
in turn directly favor exocytosis of these elements, because
the fate of any endosomal, and presumably autophagoso-
mal element, is to a large part determined by its distribu-
tion in the cell [63]. This agrees well with the observation
that Rab8 overexpression, which dramatically increases α-
SNC release from PC12 nerve cells [10], immobilizes
LC3-positive autophagosomes/amphisomes at the cell per-
iphery (unpublished data; FV).
Differences in subcellular distribution of JNK activity,
isoform activation, and temporal activation patterns likely
also explain the lack of strict correlation between JNK ac-
tivation and α-SNC secretion under different stress condi-
tions. For example, exogenous oxidative stress increases
α-SNC secretion without any overt JNK activation in both
cell lines, and in SH-SY5Y cells, ER stress imposed with
tunicamycin and thapsigargin similarly increases α-SNC
release under conditions where JNK activity is actually
depressed. On the other hand, ER stress in PC12 cells
increased both JNK activation and α-SNC secretion in a
dose-dependent manner. However, we did not investigate
the dependency of release on either JNK (isoforms) or au-
tophagy in these alternative stress conditions. For now, we
therefore specifically conclude that the increase in α-SNC
secretion following either amphisome accumulation asso-
ciated with lysosomal fusion deficiency or (select) cytokine
signaling relies on the ability of JNK2 and JNK3 activation
to promote exophagy of α-SNC.
Reciprocal interactions between microglia and neurons
activate microglia and increase α-SNC release from neurons
Microglia are essential for the development of full-blown
neurodegenerative disease, but their contribution has
mainly been relegated to the terminal phase of disease,
(See figure on previous page.)
Fig. 9 Lack of correlation between α-SNC secretion and JNK activation subsequent to ER stress or oxidative stress. a Differentiated PC12 cells
expressing α-SNC or BDNF-differentiated SH-SY5Y cells expressing α-SNCA30P were treated overnight with tunicamycin (250 and 500 ng/ml) or
thapsigargin (50 and 75 nM for PC12 cells, 25 and 50 nM for SHSY-5Y cells) or xanthine/xanthine oxidase (50 μM/0.02 U/ml and 100 μM/0.02 U/ml)
before collection of conditioned medium and cell lysates for western blotting as indicated. b–e Bar graphs show integrated optical density (IOD) of
western blot bands from above as indicated for antigen and cell line. Results are expressed as mean normalized IOD relative to control (no treatment)
±SEM and represent data from three independent experiments (*p < 0.05 by Student’s t test compared to “Control”)
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where classically activated microglia exert neurotoxic ef-
fects by the production of reactive oxygen species [38]
and other pro-inflammatory mediators [64]. However, in
animal models as well as humans, microglia activation is
widespread in the brain years or even decades before
clinical symptoms. Differentiated PC12 nerve cells ex-
pressing α-SNC activated oxidant production of either
resting or LPS-primed microglia in co-culture, as reported
previously [65], and this was enhanced by the p25α co-
expression in nerve cells, which increases α-SNC release.
Microglial oxidant production was not only increased
in direct co-culture, also passive transfer of neuron-
conditioned media was able to induce increased micro-
glial ROS production. While we have not sought to
identify the neuronal factors responsible for microglia
activation, it is reasonable to assume that the microglia
are responding to released α-SNC oligomers and aggre-
gates, which have recently been shown to engage TLR2
[40] and CR3 [41] scavenger receptors to activate
microglia. In agreement herewith, we observe that in-
ternalized α-SNC in microglia colocalize in part with
TLR2, and to a smaller degree with CD11b.
Activated microglia produce a range of inflammatory
molecules that are neurotoxic at high concentrations. We
show that classically activated (LPS; M1 activation), but
not resting, microglia increase neuronal JNK phosphoryl-
ation and α-SNC secretion (in the absence of neuronal
p25α expression). In co-culture, LPS-activated primary
microglia from neonatal rats caused NGF-differentiated
PC12 cells to secrete almost fourfold more α-SNC com-
pared to controls. Passive transfer of conditioned media
from microglial monocultures to neuronal monocultures
allowed us to establish that the increased α-SNC secretion
was accompanied by neuronal JNK phosphorylation. This
experiment also excludes oxidants (because of their lim-
ited half-life) as the microglia-derived factor that directly
influences neuronal p-JNK and α-SNC release. Thus, the
potentiation of α-SNC secretion we observe in neurons
exposed to conditioned medium from Ra2 microglia over-
expressing gp91phox is likely a property of an altered
microglial redox balance, which eventually supports in-
flammatory mediator expression [52]. One such classical
factor secreted from activated microglia is TNFα [39, 52].
TNFα dose- and time-dependently significantly increased
α-SNC secretion from both differentiated PC12 and SH-
SY5Y cells by approximately two- to fourfold, and this
correlated with JNK activation, again in the absence of
p25α expression. Further, the increased α-SNC secretion
afforded by TNFα required JNK, as shRNA knockdown of
JNK2 in PC12 cells and JNK3 in SH-SY5Y cells reduced
TNFα-induced α-SNC secretion. We note that JNK2 and
JNK3 knockdown also under non-stimulated conditions
(control cells) decrease α-SNC secretion in PC12 and
SH-SY5Ycells, respectively, suggesting a basal mechanism.
TNFα can be toxic to neurons at concentrations similar to
the ones used here [66], but in our hands, there ap-
peared no relevant toxicity (measured by LDH release
and flow cytometric probes of cell death and membrane
permeability), and morphological differentiation remained
unaltered (or even slightly enhanced). The ability to induce
an augmented release of α-SNC from PC12 nerve cells is
not unique to TNFα or pro-inflammatory mediators: of a
handful of cytokines tested with known neuronal receptors,
anti/non-inflammatory cytokines TGFβ1 and IFNβ1, both
increased α-SNC secretion from neurons in monoculture.
A few studies have documented that cytokines can in-
duce autophagy [67], but we do not know how TNFα, or
activated microglia for that matter, induce augmented
neuronal α-SNC secretion by exocytosis of amphisomes.
We do, however, implicate activated stress kinases JNK2
or JNK3 as essential components in the process. Of note,
JNK activity is increased in post-mortem brains from PD
patients [68]. Intriguingly, modest JNK inhibition in
animal models of PD ameliorates motoric symptoms
via unknown mechanisms [69, 70] that may relay to
microglia activation [71] and/or conceivably to a mech-
anism as proposed above.
Rationally, any alterations in the exophagosomal release
of α-SNC from neurons following exogenous stimulation
would ultimately have to impinge on either autophagoso-
mal uptake of α-SNC or on exocytosis of amphisomes.
Future work is directed at understanding how JNK and
cell non-autonomous mechanisms determine the burden
of α-SNC released into the surroundings.
Conclusions
In conclusion, we implicate stress kinases of the JNK
family in the regulation of exophagy and release of α-
SNC from nerve cells following both endogenous (p25α
or bafilomycin-mediated disruption of autophagosomal
flow) or exogenous stress (pro-inflammatory microglia
and their cytokine products including TNFα). In a larger
scope, our results insinuate that inflammatory microglia
may harbor a so far unforeseen wickedness: in addition
to inflicting direct bystander damage to neurons in late
phases of inflammatory brain disease, they may also be
essential mediators of early disease propagation by pro-
moting the spread of proteopathic seeds.
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